rxstat › Shortages › Oxycodone
Oxycodone shortage status
Partial shortage
Source: Health Canada shortage reports · Updated Jul 9, 2026
Some Oxycodone products are in shortage in Canada (2 of 35 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Jul 24, 2026.
In shortage since
Apr 21, 2026
Est. full return
Jul 24, 2026
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.
Reports by product
Active shortageAPO-OXYCODONE CR
80.0MG · TABLET (EXTENDED-RELEASE) · APOTEX INC
DIN 02366789 · since Jun 9, 2026, est. end Jul 24, 2026 · Disruption of the manufacture of the drug.
Active shortageAPO-OXYCODONE CR
40MG · TABLET (EXTENDED-RELEASE) · APOTEX INC
DIN 02306530 · since Apr 21, 2026, est. end May 1, 2026 · Disruption of the manufacture of the drug.
ResolvedSUPEUDOL 20
20MG · TABLET · SANDOZ CANADA INCORPORATED
DIN 02262983 · ended Aug 11, 2025 · Requirements related to complying with good manufacturing practices.
ResolvedOXY.IR
5MG · TABLET · PURDUE PHARMA
DIN 02231934 · ended Aug 1, 2025 · Demand increase for the drug.
ResolvedSUPEUDOL 5
5MG · TABLET · SANDOZ CANADA INCORPORATED
DIN 00789739 · ended May 19, 2025 · Disruption of the manufacture of the drug.
ResolvedSUPEUDOL 10
10MG · TABLET · SANDOZ CANADA INCORPORATED
DIN 00443948 · ended May 19, 2025 · Disruption of the manufacture of the drug.
ResolvedPMS-OXYCODONE
20MG · TABLET · PHARMASCIENCE INC
DIN 02319993 · ended Apr 24, 2025 · Disruption of the manufacture of the drug.
ResolvedOXY.IR
10MG · TABLET · PURDUE PHARMA
DIN 02240131 · ended Nov 29, 2024 · Demand increase for the drug.
ResolvedOXY.IR
5MG · TABLET · PURDUE PHARMA
DIN 02231934 · ended Nov 25, 2024 · Demand increase for the drug.
ResolvedSUPEUDOL 10
10MG · SUPPOSITORY · SANDOZ CANADA INCORPORATED
DIN 00392480 · ended Dec 13, 2023 · Disruption of the manufacture of the drug.
ResolvedSUPEUDOL
20MG · TABLET · SANDOZ CANADA INCORPORATED
DIN 02262983 · ended Nov 20, 2023 · Disruption of the manufacture of the drug.
ResolvedAPO-OXYCODONE CR
15MG · TABLET (EXTENDED-RELEASE) · APOTEX INC
DIN 02394766 · ended Nov 3, 2023 · Disruption of the manufacture of the drug.
Showing 12 of 60 reports. All reports are on file with Health Canada.
What's happening
Oxycodone is currently affected by 2 active shortage reports filed with Health Canada by APOTEX INC.
The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Oxycodone is classified under “OPIOIDS” (ATC N02AA).
Recent changes
Common questions
When will Oxycodone be back in stock in Canada?
The latest manufacturer estimate is Jul 24, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.
Why is Oxycodone in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Related drugs (opioids)
All opioids shortage statuses →
Guides: what to do when your medication is in shortage · how to read shortage reports
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.